Each of these three small-cap biotech stocks surged more than 100% last week. The author of today’s article notes that “It isn’t unusual to see small-cap biotechs with nine-figure market caps continue to make further gains, but they don’t always continue rising.” So which of these three small-cap biotechs might be at the beginning of a much larger move higher? CLICK HERE.
Recent Posts
- “Gigantic Upside Potential”: 5 Buy-Rated, Under-$10 Stocks For Aggressive Investors
- 4 Tech Stocks To Watch As Investors Go Back To Last Year’s Playbook
- Better Know These Lesser-Known Biotech Stocks That Have Been Surging
- 5 Buy-Rated Stocks Priced Under $10 Offering Solid Alpha Potential
- “In A League Of Its Own”: This Immuno-Oncology Stock’s Great Run In 2020 May Have Just Been The Beginning
Categories
Download This Free Report
